DSpace logo

Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 41-50 of 99 (Search time: 0.002 seconds).
Item hits:
Issue DateTitleAuthor(s)
2016-06Antidepressant- and anxiolytic-like effect of novel 5-hydroxytryptamine3 receptor antagonist 2-[4-(3-chlorophenyl) piperazin-1-yl]-1,8-naphthyridine -3-carboxylic acid (7e)- An approach using rodent behavioral antidepressant and anxiolytic test batteryMahesh, R.
2017-08Ondansetron ameliorates depression associated with obesity in high-fat diet fed experimental mice: An investigation-based on the behavioral, biochemical, and molecular approachMahesh, R.
2014-04Role of Serotonin Type-1A/B (Hydroxytryptamine) Receptors in Depression RevisitedMahesh, R.
2015-05Type 4 phosphodiesterase enzyme inhibitor, rolipram rescues behavioral deficits in olfactory bulbectomy models of depression: Involvement of hypothalamic–pituitary–adrenal axis, cAMP signaling aspects and antioxidant defense systemMahesh, R.
2015Insignificant in vitro falcipain-2 inhibitory activity of novel 2-(4-(substituted benzoyl) piperazine-1-yl)-N-phenylacetamide derivativesMahesh, R.
2010Demographic study on disease prevalence and their treatment pattern in a local hospital of a semi-urban communityMahesh, R.
2013Anxiolytic Effect of a Novel 5-HT3 Receptor Antagonist (4-Phenylpiperazin-1-yl)(Quinoxalin-2-yl) Methanone (4a) in a Battery of Behavioral Models for Anxiety in MiceMahesh, R.
2015-01Piperazine Analogs of Naphthyridine-3-carboxamides and Indole-2-carboxamides: Novel 5-HT3 Receptor Antagonists with Antidepressant-Like ActivityMahesh, R.
2010-02Review: The auspicious role of the 5-HT3 receptor in depression: a probable neuronal target?Mahesh, R.
2016-014i (N-(3-Chloro-2-methylphenyl) quinoxalin-2-carboxamide), a novel 5-HT3 receptor antagonist alleviates depressive behavior evoked in streptozotocin-induced diabetic mice: Role of oxidative stressMahesh, R.